News from augurex life sciences corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 29, 2014, 14:21 ET

Arthritis Blood Test: 14-3-3 eta Ground-Breaking Data

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the...

Oct 25, 2013, 14:33 ET

Rheumatoid Arthritis Blood Test (14-3-3eta) Data to be Presented at the World's Premier Arthritis Conference

VANCOUVER, Oct. 25, 2013 /PRNewswire/ - Augurex Life Sciences Corp. announced today the expansion of key data related to its innovative 14-3-3eta...

Nov 14, 2012, 16:00 ET

Blood marker can help diagnose Rheumatoid Arthritis; New data at the 2012 Annual Meeting of the American College of Rheumatology

VANCOUVER, Nov. 14, 2012 /PRNewswire/ - International arthritis investigators this week at the 2012 Annual Meeting of the American College of...

Oct 09, 2012, 15:59 ET

Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker 14-3-3η as a Testing Service in the U.S.

VANCOUVER, Oct. 9, 2012 /PRNewswire/ - Augurex Life Sciences Corp. today announced that it has formed an exclusive license agreement with Quest...

May 28, 2011, 07:00 ET

Augurex Reports Positive Data for RA Blood Test and Drug Target at the Annual European Congress of Rheumatology (EULAR)

Company's novel biomarker and drug target could represent the first personalized medicine in RA-promise for future targeted therapy in a...

May 28, 2011, 07:00 ET

Augurex berichtet bei der jährlichen Europäischen Konferenz der Rheumatologen (EULAR) positive Daten für RA-Bluttest und Wirkstoffziel

- Der neue Biomarker des Unternehmens und das Wirkstoffziel könnten die erste, personalisierte Medizin für Rheumatoide Arthritis(RA)...

May 28, 2011, 07:00 ET

Augurex rapporte des données positives sur le test sanguin et la cible médicamenteuse pour l'Arthrose Rhumatoïde (AR) au Congrès annuel européen sur la rhumatologie (EULAR)

- Le nouveau biomarqueur et la cible médicamenteuse de la société pourraient devenir le premier médicament personnalisé...

May 28, 2011, 07:00 ET

Augurex ha presentado datos positivos de los test de sangre de AR y objetivo de fármacos en EULAR

- Augurex ha presentado datos positivos de los test de sangre de artritis reumatoide y objetivo de fármacos en el Congreso Europeo Anual...